cTn和BNP/NT-proBNP检测在急性冠脉综合征中的应用  

The applications of cTn and BNP/NT-proBNP testingin patients with acute coronary syndrome

作　　者：赵强[1] 肖强[1] 李元民[1] 郭军凤[1] 康玲[1] 李秀昌[1] 

机构地区：[1]泰山医学院附属医院,山东泰安271000

出　　处：《中国科技信息》2013年第21期157-159,共3页China Science and Technology Information

基　　金：山东省医药卫生科技发展计划项目(No.2009HZ097)

摘　　要：急性冠状动脉综合征(ACS)是导致急性心肌缺血的一大类临床综合征,早期评估其病变程度及其预后有着重要的临床意义。cTn与BNP/NT-proBNP被认为各自都可单独作为诊断心肌缺血、进行ACS危险分层评估、预测近期心脏不良事件的有力参考指标,但是它们的联合检测对ACS患者危险性的判断及其预后的评估有着更加重要的参考价值。Acute coronary syndrome （ACS） is a large class clinical syndrome which is the result of acute myocardial ischemia.Early assessment of its severity and prognosis has important clinical significance, cTn and BNP / NT-proBNP can each be considered individually as a strong reference index of diagnostic of myocardial ischemia, ACS risk stratification for assessment, prediction of adverse cardiac events in the recent, but their combined detection of patients with ACS risk judgments and assessment of prognosis has a more important reference value.

关 键 词：肌钙蛋白-I N-末端脑钠肽前体 急性冠状动脉综合征 经皮冠状动脉介入治疗 主要心脏不良事件 

分 类 号：R541.4[医药卫生—心血管疾病]